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Large cytomegalovirus (CMV)-specific CD8 T-cell responses are observed in both young and, somewhat more often, old people.
Frequent CMV reactivation is thought to exhaust these cells and render them dysfunctional so that larger numbers of them are
needed to control CMV. Expansions of CMV-specific CD4 T cells are also seen but are less well studied. In this study, we exam-
ined the T-cell response to the dominant CMV pp65 and IE-1 antigens in healthy CMV-infected people across a wide age range
(20 to 84 years) by using multicolor flow cytometry. CMV-specific T cells were characterized by the activationmarkers CD40
ligand (CD40L), interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-), and gamma interferon (IFN-) and the memory
markers CD27 and CD45RA. The proportions of effector memory T cells increased in large responses, as did the proportions of
polyfunctional CD8 (IFN- IL-2/ TNF-) and CD4 (CD40L/ IFN- IL-2 TNF-) T-cell subsets, while the propor-
tion of naïve T cells decreased. The bigger the CD4 or CD8 T-cell response to pp65, the larger was the proportion of T cells with
an advancedmemory phenotype in the entire (including non-CMV-specific) T-cell compartment. In addition, the number of
activationmarkers per cell correlated with the degree of T-cell receptor downregulation, suggesting increased antigen sensitivity
in polyfunctional cells. In summary, our findings show that polyfunctional CMV-specific T cells were not superseded by dys-
functional cells, even in very large responses. At the same time, however, the memory subset composition of the entire T-cell
compartment correlated with the size of the T-cell response to CMV pp65, confirming a strong effect of CMV infection on the
immune systems of some, but not all, infected people.
Large cytomegalovirus (CMV)-specific T-cell responses arequite common in both young and old CMV-infected people.
This is the result of memory T-cell inflation, which is best de-
scribed for themurine cytomegalovirus (MCMV)model and con-
sists of a persistence and steady increase of the number of certain
T cells selected during (primary) infection (18, 43). These en-
larged T-cell responses, in particular CD8 responses, have been
described as “degenerated” because they appear to accumulate T
cells with a limited cytokine profile and reduced proliferative po-
tential that have an advanced to late differentiation phenotype
(14, 30, 31). It is important that dysfunctional T cells may occur in
young people and that this may be related to the duration of the
infection rather than the age of the donor, but at an older age, the
chances of having been infected with CMV for a longer period are
obviously greater (16). Unfortunately, there is usually no way of
knowing the timeofprimaryCMVinfection, exceptwhen itoccurs as
a result of transplantation or transfusion of an organ or cells, respec-
tively, from a CMV-infected donor to a CMV-negative recipient.
CMV-induced changes, along with other changes of the im-
mune system, are thought to result in increased susceptibility to
infection and decreased vaccine efficiency, in particular in older
life (24, 32). Unfortunately, in terms of immunological parame-
ters, the decline of anti-infectious immunity is difficult to quantify
because no clear and measurable correlates of protective immu-
nity are known to date. The most commonly used parameter to
investigate CMV-specific T-cell responses is the frequency of ei-
ther CD4 or CD8 T cells producing gamma interferon (IFN-)
after short-term stimulation (4, 6, 13, 21, 22, 37, 40, 41, 44). Al-
though IFN- is thought to play an important role in the control
of various infections, the frequency of IFN--producing T cells
alone does not seem to be a good correlate of protection (11, 12).
However, a recent and widely accepted concept suggests that poly-
functional T cells, in particular those simultaneously producing
interleukin-2 (IL-2), tumor necrosis factor alpha (TNF-), and
IFN- upon antigen challenge, are a crucial factor in controlling in-
fection (1, 3, 9, 11, 27). Khan et al. previously reported that the pro-
portion of IFN--producing effector cells among CMV tetramer-
bindingCD8T cells is reduced in old age (22).However, the number
of tetramer-binding CD8 T cells was increased so strongly in older
people that there was an actual net increase in the overall number of
IFN--producing CD8 T cells. This observation was confirmed in
principle by Vescovini et al., who recently reported that CMV-
specific IFN-- and TNF--producing T cells (functions measured
separately) are increased in old age, in both absolute (cells per ml of
blood) and relative (% of respective T-cell subset) terms (49).
We were intrigued by the idea that in CMV-infected individu-
als—contrary to the prevailing opinion—the numbers of fully
functioning polyfunctional CMV-specificT cellsmight actually be
stable or even increase in very large responses. Our study therefore
examined pp65-specific CD4 and CD8 T cells (CD4/pp65 and
CD8/pp65 responses) and IE-1-specific CD8 T cells (CD8/IE-1 re-
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sponse) with regard to memory subset distribution and polyfunc-
tionality inpeople between20and84years of age.The results showed
an unexpected accumulation of polyfunctional CMV-specific T cells
in individuals with largeCMV-specific responses, in both relative (%
of respective subset [CD4 or CD8]) and absolute (cells per ml of
blood) terms. Moreover, we found that the size of the pp65-specific
T-cell response (rather than just its presence) positively correlated
withanadvancingdegreeof terminalT-cell differentiation ingeneral,
including that of non-CMV-specific T cells.
MATERIALS AND METHODS
Volunteer sample collection and isolation. Heparinized peripheral
blood was collected from over 100 healthy donors. CMV serostatus was
tested in all individuals. T-cell responses to the CMV proteins pp65 and
IE-1 were tested in all seropositive individuals and all individuals for
whom serology was not available at the time of testing, which included
some seronegative individuals. A total of 41 CMV-seropositive donors
with T-cell responses to pp65 or IE-1 above 1/10,000 of the reference
subset (CD4orCD8T cells)were included in this study. The age rangewas
20 to 84 years; 27 donors were female (mean age  standard deviation
[SD], 53  21 years), and 14 were male (57  20 years). Young donors
were recruited from healthy university staff and students. Older volun-
teers were recruited from the general public through the Clinical Investi-
gation and Research Unit (Brighton and Sussex University Hospital
Trust) and through general practitioner (GP) practices, with assistance
from the NIHR Primary Care Research Network; all older subjects were
mobile, were not suffering from acute or chronic illness, and were not on
medication known to affect the immune system. The study was in agree-
ment with the Declaration of Helsinki and was approved by the relevant
University and National Health Service (NHS) ethics committees. All do-
nors gave written informed consent. Peripheral blood mononuclear cells
(PBMCs) were isolated by Ficoll-Hypaque (Amersham Pharmacia Bio-
tech, Uppsala, Sweden) density gradient centrifugation.
Antibodies. Fluorochrome-conjugated antibodies were obtained from
the following companies: anti-TNF-–Alexa 700, anti-IL-2–allophycocyanin
(APC), anti-CD8–APC–H7, anti-CD8–peridinin chlorophyll protein
(PerCP), anti-CD4–PerCP, anti-CD40 ligand (CD40L)–phycoerythrin (PE),
anti-IFN-–PE–Cy7, anti-CD27–PE, anti-CD16–fluorescein isothiocyanate
(FITC), anti-CD56–FITC, and anti-CD45–PerCPwere fromBDBiosciences
(San Jose, CA); anti-CD45RA–Texas Red–PE and anti-CD4–Texas Red–PE
were fromBeckmannCoulter (Fullerton,CA); anti-CD3–QDot605andaqua
blue live-dead stain were from Invitrogen (Paisley, United Kingdom); and
anti-CD3–Pacificbluewas fromCambridgeBiosciences (Cambridge,United
Kingdom).
CMV serology. Plasmas or sera from all donors were tested for CMV-
specific IgG and IgM by an automated CMV enzyme-linked immunosor-
bent assay (ELISA) (Department of Microbiology, Royal Sussex County
Hospital, Brighton, United Kingdom).
Whole-blood counting and staining.Leukocytes in freshwhole blood
were counted for all but two donors. One hundred microliters of whole
blood was stained with pretitrated surface antibodies (to CD45, CD3,
CD4, and CD8) for 30 min at 4°C, lysed for 10 min at room temperature,
and washed, and flow cytometry data were acquired immediately.
Cell stimulation and staining. The method of cell stimulation was
described previously in more detail (4). In brief, 400 l of PBMC suspen-
sion (2 106 cells/ml) was stimulatedwith pp65 or IE-1 spanning peptide
pools (1 g/ml per peptide; JPT Peptide Technologies, Berlin, Germany)
FIG 1 Frequencies and absolute numbers of pp65-specific T cells are not closely correlated with age. Responding T cells were defined as those displaying at least
one of the activation markers CD40L, IL-2, IFN-, and TNF-. Frequencies (left) and absolute numbers (right) of responding CD8/pp65 (top) and CD4/pp65
(bottom) T cells are displayed. Absolute and relative values followed a lognormal distribution and were log transformed to better visualize changes with age.
There was no detectable correlation of T-cell responsiveness to pp65 with age.
Lachmann et al.
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dissolved in dimethyl sulfoxide (DMSO; Pierce, Germany) for 2 h at 37°C.
Peptide pools were composed of 15 amino acid peptides with 11 overlaps,
beginning at the first amino acid of the published sequence for pp65
(Swiss-Prot accession no. P06725; 138 peptides) or IE-1 (Swiss-Prot ac-
cession no. P13202; 121 peptides). Stimulation with purified protein de-
rivative (PPD) (10 g/ml; Statens Serum Institute, Copenhagen, Den-
mark) was performed for a subgroup of individuals. OKT3 (0.5 g/ml)
was used as a positive control, and DMSO (equivalent to the amount
added with peptide pools) was added to unstimulated samples (negative
control). After the addition of brefeldin A (10 g/ml; Sigma), samples were
incubated for another 14 h and then washed (in phosphate-buffered saline
[PBS] containing 0.5% bovine serum albumin and 0.1% sodium azide) and
stained with pretitrated surface antibodies for 30 min at 4°C. After washing,
lysis, andpermeabilization (Perm2andLysis reagents [BDBiosciences], used
according to the manufacturer’s instructions), cells were stained intracellu-
larly (30 min, 4°C). Following staining, cells were washed, fixed in PBS con-
taining 0.5%paraformaldehyde, and acquired on a BDLSRII flow cytometer
using FACSdiva 6.1 software (both from BD Biosciences).
Data analysis. Data analysis was performed using FlowJo software
(Treestar, OR). A lymphocyte gate, singlet gate (FSC-A versus FSC-H),
live/dead gate, CD3 T-cell gate, CD4 andCD8T-cell gates, memory T-cell
subset gates, and activated cell gates (activation marker positive) were
applied sequentially according to a set gating strategy. For the purpose of
this study, cells displaying at least one of the four analyzed activation
markers upon antigen stimulation were called antigen specific.
Statistical analysis. Statistical analysis was performed using SPSS 18.
Both relative and absolute counts for CD4 T cells, CD8 T cells, and the
pp65- and IE-1-specific responses fitted a lognormal distribution. For
visualization of data, cell counts were represented as log-transformed data
except where non-log-transformed data were better suited to show the
effects of small changes in response size. The relationship between the
analyzed parameters was generally assumed to be nonlinear, and Spear-
man’s correlation coefficient (RS) was used for all correlations. When a
normal distribution could not be shown (by the Kolmogorov-Smirnoff
test and Q-Q plots), statistical tests for nonparametric data were used. P
values of0.05 were considered significant. Mean fluorescence intensity
(MFI) values were standardized using Z scores in order to allow compar-
isons between different subjects.
RESULTS
CMV-specific T-cell response size correlates only loosely with
age. T cells expressing one or more of the activation markers
CD40L, IFN-, IL-2, and TNF- were considered activated and
antigen specific. Response size was measured either as a percent-
age of the reference subset (CD8 or CD4 T cells) or as the number
of cells per ml of blood (absolute counts). Figure 1 shows CD8/
pp65 andCD4/pp65 responses as percentages and absolute counts
versus donor age.Up to approximately 11%ofCD8T cells and 6%
of CD4 T cells responded to pp65 in this cohort, which is in line
with previously published data (19, 20, 45). As expected for a
human population, large variations in response size were visible
across all ages. A (nonsignificant) trend toward an increase of
response size with age was visible for both CD8/pp65 and CD8/
IE-1 responses (the latter not shown) and also for CD4/pp65 re-
sponses. CD4/IE-1 responses were inconsistent and small and
therefore were not considered further. Very large CD8/pp65 and
CD4/pp65 responses seemed to occur preferentially in older peo-
ple. Statistical analysis revealed that both relative and absolute
counts of these responses fitted a lognormal distribution.Notably,
there was no significant correlation between the absolute size of
FIG2 Large pp65-specific T-cell responses show amore advancedmemoryT-cell subset composition. (A andB)The absolute counts of CMVpp65-specificCD8
and CD4 T cells do not correlate significantly with the absolute numbers of CD8 and CD4 T cells in peripheral blood. (C and D) There is an overproportioned
(nonlinear) relative increase in pp65-specific TEM cells and decrease in TNAIVE cells within these responses. (E and F) The proportions of the entire TNAIVE and
TEM CD8 and CD4 T-cell compartments (C and D) are changed in the presence of large pp65-specific responses. ns, not significant.
Polyfunctionality of CMV-Speciﬁc T Cell Responses
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the entire CD4 or CD8 T-cell compartment and the size of the
CMV-specific CD8 or CD4 T-cell response (in cells/ml of blood)
(Fig. 2A and B).
The increase of the effector memory T-cell compartment is
overproportioned in large responses. By convention, T-cell
memory compartments are referred to as naïve (TNAIVE;
CD45RA CD27), central memory (TCM; CD45RA
CD27), effector memory (TEM; CD45RA CD27), and re-
vertant (TEMRA; CD45RA CD27) cells (2, 15). Please note
that with respect to the naïve compartment, this terminology is
not entirely accurate, since naïve cells are not expected to re-
spond to antigen stimulation by producing effector cytokines
or to occur in large frequencies. The size of the pp65-specific
CD8 T-cell response correlated significantly with a relative loss
of TNAIVE cells within the pp65-specific CD8 T-cell compart-
ment but not with an increase in TEM cells (Fig. 2C). However,
the proportions of TNAIVE and TEM cells in the entire CD8 T-cell
compartment, which usually includes a very large majority of non-
CMV-specific T cells (45), both correlated significantly with the size
of the pp65-specific T-cell response (Fig. 2E). The decline of the pro-
portion of all naïve CD8 T cells also correlated significantly with the
size of the CD8/IE-1 response (0.521; P 0.001; n 36) (data not
shown).Changes in the proportions ofT-cellmemory subsetswithin
and outside the pp65-specificCD4T-cell compartment correlated in
a very similar way with the size of the CD4/pp65 response (Fig. 2D
andF).Notallmemorycompartmentswereaffected in the sameclear
waybyresponse size (seeFig. S1andS2 in the supplementalmaterial).
As a result, the degree of advanced T-cell memory differentiation
within the CMV-specific T-cell compartment (Fig. 2C and D), but
also outside it (Fig. 2E and F), seemed to be related to the size of the
CMV pp65-specific T-cell response.
Polyfunctional components of CMV-specific T-cell re-
sponses grow with increasing response size. Two functional
subsets correlated particularly well with the sizes of CD8/pp65
responses (Fig. 3). These included CD8 T cells that were either
IFN- IL-2 TNF- or IFN- TNF-. These subsets
were found primarily in TEM cells and, to some extent, in the
TCM and TEMRA compartments. Both subsets also correlated
with CD8/IE-1 cell expansion (RS 0.609, P 0.000, and n
36 and RS  0.475, P  0.003, and n  36, respectively). The
FIG 3 Large CMV-specific CD8 T-cell responses have large polyfunctional components. Data are presented as dots correlating the absolute numbers of
CD8/pp65 T cells displaying the indicated combinations of activationmarkers to the absolute number of all responding CD8/pp65 T cells (displaying at least one
of the activationmarkers) (n 39). The Spearman rank correlation coefficient for nonparametric data (RS) is indicated for significant correlations (RS of0.50).
Certain donors did not express certain functional subsets, resulting in what appears to be two groups with respect to each subset, but the nonresponding donors
varied. However, the IFN- IL-2 TNF- subset was expressed by most donors. Cell counts were log transformed, with zeroes assigned the value 0.01 prior
to transformation. The size of responding subsets is given as log(cells/ml of blood).
Lachmann et al.
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subsets whose size correlated most strongly with the size of the
CD4/pp65 response were CD40L IFN- IL-2 TNF- and
IFN- IL-2 TNF- cells; these corresponded to the subset
that was most strongly associated with the CD8/pp65 response,
with or without additional CD40L upregulation (Fig. 4). For
each subset, there was a number of donors not expressing this
particularmarker combination, but these donors varied from subset
to subset.Note that an increaseofpp65-specificTcellshavingnoneof
the functionswemeasured is not ruledoutbyourfindings.However,
because the frequencies of polyfunctional T cells were measured as
percentages of all CD4 or all CD8T cells or in absolute counts perml
of blood, it can be excluded fully that nonfunctional T cells replaced
polyfunctional T cells. Figure 5 shows representative raw data for an
older individual.
The degree of polyfunctionality of CMV-specific T cells cor-
relateswith thedegree ofTCRdownregulation and the amounts
of cytokines per cell. T-cell receptor (TCR) downregulation was
examined because it is a marker of T-cell sensitivity and correlates
with the degree of T-cell activation. It was measured as theMFI of
CD3, CD4, or CD8 expression. To allow for comparisons between
individuals in different experimental runs,MFIswere normalized.
The higher the number of activation markers displayed simulta-
neously per T cell, the stronger was not only CD3 but also CD8
and CD4 downregulation (Fig. 6). This was observed for CD8/
pp65 T cells, CD8/IE-1 T cells, and CD4/pp65 T cells, as well as in
OKT3-stimulated CD8 and CD4 T cells and PPD-stimulated CD4
T cells. OKT3 and PPD were tested for comparison (data not
shown). Furthermore, and in agreement with other reports, the
degree of polyfunctionality (i.e., the number of different activa-
tion markers displayed at the same time) correlated with the
amount of each activation marker expressed per cell (normalized
MFI), except for IL-2, which was expressed more highly in cells
displaying just two functions (Fig. 7) (11, 17, 38, 39). This is fur-
ther illustrated for IFN- and TNF- in Fig. S3 in the supplemen-
tal material.
DISCUSSION
In the literature, large CMV-specific T-cell responses are fre-
quently described in the context of old age; these responses are
usually reported as percentages of IFN--producing or tetramer-
FIG 4 Large CMV-specific CD4 T-cell responses have large polyfunctional components. Data are presented as dots correlating the absolute numbers of
CD4/pp65 T cells displaying the indicated combinations of activationmarkers to the absolute number of all responding CD4/pp65 T cells (displaying at least one
of the activationmarkers) (n 38). The Spearman rank correlation coefficient for nonparametric data (RS) is indicated for significant correlations (RS of0.50).
Certain donors did not express certain functional subsets, resulting in what appears to be two groups with respect to each subset, but the nonresponding donors
varied.However, theCD40L IFN- IL-2TNF- subset was expressed bymost donors. Cell countswere log transformed,with zeroes assigned the value 0.01
prior to transformation. The size of responding subsets is given as log(cells/ml of blood).
Polyfunctionality of CMV-Speciﬁc T Cell Responses
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binding CD8 T cells (22, 29, 31–34, 49). However, large CMV-
specific responses also occur in young people (19, 45). Studies
carried out on CMV-negative transplant recipients of CMV-
positive grafts suggested that the size of the T-cell response to
CMV correlates with the duration of CMV infection (36), and it is
likely that this holds true for healthy CMV-infected individuals,
too. However, we believe that in addition to the length of infec-
tion, host factors are crucial for the development of very large
responses. This was suggested by long-term prospective studies of
ageing cohorts, the OCTO and NONA studies, where an immune
risk phenotype (IRP) thought to result from CMV infection was
identified only in a subset of CMV-infected participants. It in-
cluded CMV seropositivity and the expansion (inflation) of CD8
T cells with an advancedmemory phenotype. This is probably the
result of advanced memory differentiation of CMV-specific and
non-CMV-specific T cells, where the latter may be driven in a still
unknown way by an inflated CMV-specific T-cell response. Why
this inflation occurs in some but not all CMV-infected individuals
is unclear; to date, CMV-related memory T-cell inflation is best
studied in MCMVmodels but is still not fully understood (18). It
is one attractive hypothesis that the selection of “inflating” T-cell
specificities is related to the composition of the naïve TCR reper-
toire (35). Other factors could also be involved in this process,
including viral factors. Unfortunately, no study of humans or
FIG 5 Example of original data for an older individual. Representative dot plots show different views of the same data. CD4 and CD8 T cells were gated from
single lymphocytes (FCS-H/FSC-A). Activated cells were gated individually for each T-cell subset and activationmarker, and then Boolean gating combinations
were computed. For the purpose of illustration only, all cytokines were plotted against CD40L. Plots show log fluorescence intensities for all markers. Side scatter
(SSC) and forward scatter (FSC) are shown on a linear scale. More than 400,000 lymphocytes were gated in the example.
Lachmann et al.
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mice has yet reported a clear effect of viral variations or gene
expression patterns on memory T-cell inflation. Also, viral load
testing is usually negative for long-term virus-infected humans,
and there is nomethod to retrospectively determine theCMV load
during primary infection, so these factors cannot be included in
the analysis. With regard to viral gene expression, it appears that
even interference with antigen presentation has little effect on
TCR selection and memory inflation patterns in the MCMV
model (25). A recent study of married couples where one of the
partners, but not the other, was the offspring of very-long-lived
parents found that the hallmarks of CMV infection (immune sys-
tem changes pertaining to the IRP) were absent in those with
long-lived parents, pointing again to an important role of host
genetic factors (10).
It was previously reported by several authors that a higher de-
gree of T-cell differentiation (i.e., the presence of more cells of a
more advanced memory type) in general is found in CMV-
infected individuals than in noninfected individuals (7, 33, 46),
but no correlationwith any quantitativemeasure of CMV-specific
immunity was established. Our results now clarify that the degree
of T-cell differentiation in general correlates with the actual size of
CD4/pp65 and CD8/pp65 responses. This is a novel and poten-
tially very important finding, because it suggests that it may be the
way inwhich the immune systemdeals with CMV that determines
if the entire T-lymphocyte compartment (including a majority of
non-CMV-specific cells) shows moderate (if the pp65-specific re-
sponse is small) or advanced (if the pp65-specific response is
large) differentiation.
It has become increasingly clear in recent years that response
size is not directly related to protection. Recent studies suggested a
critical role of T-cell response quality in the prediction of disease
outcome, particularly assigning a protective role to subsets dis-
playing several functions/activationmarkers simultaneously (1, 3,
8, 9, 11, 27, 28, 42). In particular, subsets producing IL-2, IFN-,
and TNF- at the same time have been associated with protection
from infection after vaccination (9). We found that, surprisingly,
polyfunctional CD4 and CD8 T cells were markedly increased in
large pp65-specific responses. These polyfunctional subsets were
located predominantly in the TEM compartment but also, to some
extent, in the TCM and TEMRA compartments, in agreement with
the expansion of TEM and TEMRA compartments in large re-
sponses. Several published studies reported larger numbers of
CMV-specific T cells, with a relative loss of IFN-- or TNF--
producing cells, in older CMV-positive donors (14, 22, 29, 32).
Our results clarify that irrespective of response size or age, a robust
population of polyfunctional CMV-specific T cells is present.
The degree of polyfunctionality of a T-cell response is likely to
depend on the type of antigen encountered, antigen concentra-
tion, effectiveness of antigen presentation, and stage of antigen-
dependent differentiation of the responding T cell (1, 5, 26, 47). In
T cells with high antigen sensitivity, antigen contact results in a
stronger signal than in cells with lower antigen sensitivity, and a
stronger signal then translates into a more polyfunctional profile
(1). TCR downregulation directly follows T-cell activation, and
the degree of TCR downregulation is known to correlate with
antigen sensitivity (23, 48, 50). As a result, one would expect TCR
downregulation to be linked directly to polyfunctionality, and our
results confirm exactly this prediction. Our results also confirm
that CMV-specific T cells producing multiple cytokines express
more of each cytokine per cell than single producers, which sup-
FIG 6 Downregulation of CD3, CD8, and CD4 on T cells after pp65-specific stimulation. Line curves (medians 95% confidence intervals [95%CI]) represent
CD3 andCD8 expression onCD8/pp65T cells (top panels), as well as CD3 andCD4 expression onCD4/pp65T cells (bottompanels), as a function of the number
of activation markers displayed simultaneously following overnight stimulation with a pp65 peptide pool. Lineage marker expression is represented by the
standardizedMFIs of CD3, CD8, andCD4within the respective populations. Therewas a nearly linear correlation betweenTCRdownregulation and the number
of displayed activation markers (RS is indicated; n 20 for all diagrams).
Polyfunctionality of CMV-Speciﬁc T Cell Responses
January 2012 Volume 86 Number 2 jvi.asm.org 1007
 o
n
 N
ovem
ber 14, 2013 by UNIV O
F SUSSEX
http://jvi.asm.org/
D
ow
nloaded from
 
ports the idea that they are more efficient effector cells (11, 17, 38,
39). This was observed for CD4 and CD8 T cells after stimulation
with CMV antigens but also after stimulation with PPD and
OKT3, indicating that it is a general feature of T cells and is inde-
pendent of the antigen recognized. IL-2 appeared to be an excep-
tion to this rule, which might be explained by its role early in an
immune responsewhere sustainedT-cell proliferation is required.
In conclusion, our results show that large expansions of non-
functional CMV-specific T cells do not occur at the expense of
functional cells. This observation should help to reconcile some of
the divergent views in the literature on the role of CMV-specific
T-cell expansions. At the same time, our findings clarify that the
magnitude of the effect that CMV has on general memory T-cell
subset distribution (CMV-specific and non-CMV-specific cells)
depends on the size of the pp65-specific T-cell response. This is a
significant extension of previous observations, as it links this effect
to the characteristics of the CMV-specific immune response itself
rather than the presence of CMV infection alone.
ACKNOWLEDGMENTS
We thank Becky Dilley (NIHR Primary Care Research Network South-
East) and all participating GP practices for help with recruiting suitable
donors.We acknowledge Elaine Noon for handling the informed consent
procedure, donor assessment, and sample acquisition. We are grateful to
all blood donors for their contributions.
This work was supported in part by the Brighton and Sussex Medical
School and by grant R107/0209 from the Dunhill Medical Trust (United
Kingdom).
We declare no commercial affiliations or competing financial inter-
ests.
FIG 7 Polyfunctional T cells display larger quantities of each activation marker except for IL-2. Line curves (medians  95% CI) show standardized MFIs of
IFN-, IL-2, TNF-, and CD40L. MFIs for T cells expressing one, two, three, or four activation markers are shown (n  20). Note that although IL-2 was
displayed by the major polyfunctional CD8/pp65 and CD4/pp65 subsets, its levels in responses including more than 2 markers were lower, which probably
reflects its role in early antigen-dependent T-cell differentiation/proliferation.
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